-
New research, published inΒ Nature Genetics, identified a cell membrane protein called NALCN that serves as a sodium ion channel and acts as a βkey regulatorβ of metastasis. These channels control […]
Oct 17,2022
-
New combination of three existing immunotherapy drugs may eliminate pancreatic tumors By Stephanie Elsea When it comes to fighting and destroying infected or diseased cells, T cells are the heroes. The bodyβs front line of defense, T cells are like soldiers deployed at […]
Aug 13,2021
-
As the next step in finding a potential targeted treatment for pancreatic cancer, researchers at the University of Cincinnati are publishing a new study revealing how a combination therapy may […]
Jun 08,2020
-
A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers […]
May 14,2021
-
Internationally Renowned Cancer Immunologist Elizabeth M. Jaffee, M.D. Joins the Lustgarten Foundation The Lustgarten Foundation announced today the appointment of Elizabeth M. Jaffee, M.D., the immediate past president of the […]
Apr 16,2019
-
If the American Cancer Society’s projections prove accurate, more people will die from pancreatic cancer than from breast, brain, ovarian or prostate cancer this year. One reason pancreatic cancer is […]
Jun 14,2019
-
Overall cancer survival has dramatically improved over the past two decades. However, the prognosis for pancreatic cancer remains bleak, with five-year survival at just 9 percent. Patients usually donβt have […]
Jan 06,2020
-
A team led by Frank McCormick, Ph.D., FRS, D.Sc. (Hon), RAS National Program Advisor at the Frederick National Laboratory for Cancer Research and professor emeritus at UCSF Helen Diller Family […]
Jan 28,2020